Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 21.37 CNY Market Closed
Market Cap: 60.9B CNY
Have any thoughts about
Shanghai Pharmaceuticals Holding Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Shanghai Pharmaceuticals Holding Co Ltd stock under the Base Case scenario is 74.49 CNY. Compared to the current market price of 21.37 CNY, Shanghai Pharmaceuticals Holding Co Ltd is Undervalued by 71%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
74.49 CNY
Undervaluation 71%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
74
vs Industry
87
Median 3Y
0.2
Median 5Y
0.2
Industry
2.4
Forward
0.2
More Details
15.1
P/E
P/E
Price to Earnings
15.1
vs History
3
vs Industry
34
Median 3Y
11.2
Median 5Y
11.6
Industry
23.5
Forward
16
More Details
10.7
P/OCF
P/OCF
Price to OCF
10.7
vs History
49
vs Industry
17
Median 3Y
11.6
Median 5Y
10.4
Industry
14.7
More Details
10.7
P/FCFE
P/FCFE
Price to FCFE
10.7
vs History
22
vs Industry
30
Median 3Y
9
Median 5Y
9.2
Industry
20.7
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
55
vs Industry
68
Median 3Y
0.8
Median 5Y
1
Industry
2.2
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
55
vs Industry
85
Median 3Y
0.3
Median 5Y
0.3
Industry
2.5
Forward
0.3
More Details
2.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.7
vs History
7
vs Industry
64
Median 3Y
2.3
Median 5Y
2.4
Industry
5.1
More Details
9.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.6
vs History
28
vs Industry
36
Median 3Y
7.7
Median 5Y
8.2
Industry
12.9
Forward
6.7
More Details
9.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
9.6
vs History
28
vs Industry
40
Median 3Y
7.7
Median 5Y
8.2
Industry
17.6
Forward
8.2
More Details
14.2
EV/OCF
EV/OCF
Enterprise Value to OCF
14.2
vs History
44
vs Industry
12
Median 3Y
14.4
Median 5Y
13.3
Industry
14.5
More Details
25.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25.4
vs History
41
vs Industry
17
Median 3Y
25.2
Median 5Y
21.4
Industry
18.8
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
50
vs Industry
73
Median 3Y
0.6
Median 5Y
0.6
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Shanghai Pharmaceuticals Holding Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.9B CNY 0.2 15.1 9.6 9.6
US
Mckesson Corp
NYSE:MCK
77.5B USD 0.2 30.6 18.3 21.4
US
Amerisourcebergen Corp
LSE:0HF3
48.9B USD 0.2 32.4 11.9 16.3
US
Cencora Inc
NYSE:COR
48.7B USD 0.2 32.2 11.9 16.3
US
Cardinal Health Inc
NYSE:CAH
30.4B USD 0.1 24 10.8 14.3
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD 0.7 29.7 13.1 19.3
CN
Huadong Medicine Co Ltd
SZSE:000963
65B CNY 1.6 20.2 15.4 15.4
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
65.4B HKD 0.1 7.1 1.8 2.2
IT
Amplifon SpA
MIL:AMP
5.5B EUR 2.3 35 11.2 23.4
DE
McKesson Europe AG
XHAM:CLS1
5B EUR 0.2 -5.1 3.9 19.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 204,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.